tiprankstipranks

Moderna in talks to get funding for select vaccine trials, Bloomberg reports

Moderna (MRNA) is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as it works to develop its product portfolio while cutting costs, Bloomberg’s Gerry Smith reports. The company is seeking outside deals as it navigates major changes to vaccine policy under U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and declining sales of its Covid shot. Moderna is seeking outside funding for its portfolio of vaccines that protect against viruses that can lay dormant and undetected in the body after an infection, including Epstein-Barr virus and herpes simplex virus, according to the report.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1